ENVOY MEDICAL INC (COCH) Stock Income Statement
NASDAQ:COCH - Nasdaq - US29415V1098 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 225.00K | 316.00K | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 742.00K | 789.00K | N/A | N/A | N/A | |||
| Gross Profit | -517.00K | -473.00K | N/A | N/A | N/A | |||
| Operating Expenses | 18.74M | 17.89M | 4.89M | 5.20M | 0.00 | |||
| Research and Development | 10.18M | 8.96M | N/A | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 8.56M | 8.93M | N/A | N/A | N/A | |||
| Operating Income | -19.26M | -18.36M | -4.89M | -5.20M | 0.00 | |||
| Interest Income/Expense | -1.04M | -69.00K | 26.12M | 5.50M | N/A | |||
| Other Income/Expense | -496.00K | -11.49M | -500.00K | -550.00K | N/A | |||
| Income Before Taxes | -20.80M | -29.92M | 20.74M | -250.00K | 0.00 | |||
| Income Tax | 0.00 | 0.00 | 1.50M | N/A | N/A | |||
| Net Income | -27.97M | -31.27M | 19.23M | -250.00K | 0.00 | |||
| EBITDA | -19.08M | -18.23M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.49 | -2.54 | 0.36 | -0.01 | 0.00 | |||
| Non GAAP EPS | -1.42 | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | -229.78% | -149.68% | N/A | N/A | N/A | |||
| Profit Margin | -12432.44% | -9895.89% | N/A | N/A | N/A | |||
| Operating Profit Margin | -8558.22% | -5809.81% | N/A | N/A | N/A | |||
All data in USD